JCB logo
Keystone Symposia 2009 Meetings
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 11 July 2000. doi:10.1083/jcb.150.1.131
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 363K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deshmukh, M.
Right arrow Articles by Johnson, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deshmukh, M.
Right arrow Articles by Johnson, E. M., , Jr.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2000/7/131/ $5.00
The Journal of Cell Biology, Volume 150, Number 1, July 10, 2000 131-144


Original Article

Caspase Inhibition Extends the Commitment to Neuronal Death Beyond Cytochrome c Release to the Point of Mitochondrial Depolarization

Mohanish Deshmukha, Keisuke Kuidac, and Eugene M. Johnson, Jr.a,b
a Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110
b Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110
c Vertex Pharmaceutical, Cambridge, Massachusetts 02139

Correspondence to: Eugene M. Johnson, Jr., Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110. Tel:(314) 362-3926 Fax:(314) 747-1772 E-mail:ejohnson{at}pcg.wustl.edu.

Nerve growth factor (NGF) deprivation induces a Bax-dependent, caspase-dependent programmed cell death in sympathetic neurons. We examined whether the release of cytochrome c was accompanied by the loss of mitochondrial membrane potential during sympathetic neuronal death. NGF- deprived, caspase inhibitor–treated mouse sympathetic neurons maintained mitochondrial membrane poten-tial for 25–30 h after releasing cytochrome c. NGF- deprived sympathetic neurons became committed to die, as measured by the inability of cells to be rescued by NGF readdition, at the time of cytochrome c release. In the presence of caspase inhibitor, however, this commitment to death was extended beyond the point of cytochrome c release, but only up to the subsequent point of mitochondrial membrane potential loss. Caspase-9 deficiency also arrested NGF-deprived sympathetic neurons after release of cytochrome c, and permitted these neurons to be rescued with NGF readdition. Commitment to death in the NGF-deprived, caspase- 9–deficient sympathetic neurons was also coincident with the loss of mitochondrial membrane potential. Thus, caspase inhibition extended commitment to death in trophic factor–deprived sympathetic neurons and allowed recovery of neurons arrested after the loss of cytochrome c, but not beyond the subsequent loss of mitochondrial membrane potential.

Key Words: apoptosis, caspase-9, bax, sympathetic neurons, NGF


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents